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Capacity of Rural Counties to Address an 
HIV or Hepatitis C Outbreak 
BACKGROUND 
HIV and hepatitis C (HCV) are major public health concerns in the United 
States and are a focus of significant federal health policy attention. One 
component of the federal HIV response is the U.S. Department of Health 
and Human Services initiative Ending the HIV Epidemic.¹ Launched in 2019, 
the initiative is an interagency collaboration to end the HIV epidemic in the 
United States within 10 years by leveraging advances in HIV prevention, 
diagnosis, treatment, and outbreak response.² The initiative is focusing 
resources on 57 jurisdictions with high rates of HIV transmission, including 
seven states with a substantial rural HIV burden. One of the cornerstones 
of the initiative is ensuring that HIV outbreaks are responded to quickly 
and effectively, using the best available science and technology. However, 
the Centers for Disease Control and Prevention (CDC) notes that not all US 
communities have the capacity to respond to a potential outbreak.³
Rural persons who inject drugs (PWID) report behaviors that place them at 
higher risk for acquiring HIV or HCV, including high-risk injection4,5 and 
sexual practices.⁶ Growing rural prevalence of opioid misuse and injection 
drug use (IDU) suggests that rural communities are at risk of IDU-related 
HIV or HCV outbreaks. In 2014, a notable IDU-related HIV outbreak occurred 
in Scott County, Indiana, a small community of 4,200 people. During the 
outbreak, 215 people were diagnosed with HIV, with the majority co-infected 
with HCV.7,8 Other isolated outbreaks of HIV or HCV have occurred in 
rural communities throughout the U.S. in recent years.5,9-12 Of 220 counties 
identified as vulnerable to an HIV and HCV outbreak as a result of IDU, most 
counties were rural, and over half (56 percent) were located in Appalachian 
Kentucky, Tennessee, and West Virginia.13
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Key Findings
• Local health departments 
(LHDs) located in rural 
counties in at-risk states 
are less likely to offer 
services that may help 
detect or address an HIV or 
Hepatitis C (HCV) outbreak, 
including HIV testing, HIV 
services, infectious disease 
surveillance, and substance 
use services. 
• Rural LHDs are less 
likely to report a history of 
partnerships with community-
based organizations that may 
be important resources during 
an HIV or HCV outbreak, 
including community health 
centers and faith-based 
organizations. 
For more information about this study, 
contact Erika Ziller, PhD
erika.ziller@maine.edu
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of the authors and no endorsement by FORHP, HRSA, or  HHS is intended or should be inferred.
Jennifer D. Lenardson, MHS, Jaclyn Janis, MPH, Amanda R. Burgess, MPPM, 
Karen B. Pearson, MLIS, MA, Martha Elbaum, MPA, Erika Ziller, PhD
Limited public health capacity in rural areas may contribute to increased risk for HIV/HCV outbreaks. Rural public 
health departments have significantly fewer staffing and financial resources than their urban counterparts.14 Staff 
recruitment and retention are challenged by a lack of funding and support from elected officials.15 One result of this 
lack of resources is that community health assessment and health improvement planning activities, which are required 
for public health agency accreditation, are often not performed in rural areas.16 Small health departments often lack 
emergency management services15 and are also less likely to have an emergency plan or train public health staff in 
emergency preparedness.17
Access to services for opioid use disorder (OUD) and HIV/HCV are more limited in rural areas. Service shortages, 
stigma, high costs, and a lack of integrated services, transportation, clinician diversity, and technology contribute 
to OUD treatment gaps in the rural South.18 Barriers to accessing HIV care in rural areas include lack of services,19,20 
HIV-related stigma,21 lack of knowledge or awareness of HIV at the community level, confidentiality concerns, few 
substance use disorder treatment facilities willing to work with people living with HIV/AIDS,22,23 as well as distance 
and travel time.20,24 Rural PWID with HCV face challenges in seeking and receiving treatment, including limited 
access to treatment, insurance restrictions, and clinician reluctance to treat patients who inject drugs.20 Additionally, 
individuals may not perceive a need for treatment, fear side effects, or lack knowledge of their HCV status.25
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The Ryan White HIV/AIDS Program (RWHAP) is an 
important health resource for rural and urban people 
living with HIV (PLWH) and research indicates that 
those accessing RWHAP services in rural places 
maintain service use at the same rate as their urban 
counterparts.26,27 However, these programs are not 
universally available to rural residents and the research 
did not examine rural-urban disparities in initial access to 
services.
According to the CDC and others, preventing an HIV/
HCV outbreak among PWID involves multiple ongoing 
activities including testing for infection, partner services 
and contact tracing, community education, treatment for 
mental health and substance use disorders, treatment 
for HIV/HCV, and harm reduction services such as 
syringe service programs (SSPs) and medication assisted 
treatment.28-33 This study used multiple sources of 
secondary data to examine the extent to which provision 
of these services, particularly by local health departments, 
differs by rural-urban location. 
METHODS
This brief reports on secondary data analyses that are 
part of a larger mixed-methods study designed to better 
understand the ability and resources of rural counties 
in at-risk states to address an HIV or HCV outbreak. 
We compared rural and urban states with high rates of 
problem opioid use on indicators of state and county 
health system capacity and sociodemographic and 
economic characteristics. Additional findings from 
interviews with state, county, and local administrators, 
community-based organizations, and clinicians about 
their capacity to respond to rural outbreaks are available 
in a companion article.34 
For the quantitative component of the study, we 
addressed the following research questions:
1. Do states with a higher proportion of rural
residents differ in their efforts to perform infectious
disease surveillance, provide prevention services,
and collaborate with partners and stakeholders
compared with more urban states?
2. What activities are local health departments (LHDs)
engaged in that may be considered preparation
for an HIV/HCV outbreak and is there a rural-
urban difference in these activities (e.g., services,
advocacy)?
3. What socioeconomic characteristics are present
in counties at potential risk, and what health
professionals and health facility resources are
available in the event of an outbreak?
State Selection
Because the opioid crisis and IDU differ across regions 
and states, we focused our analyses on 20 states that we 
identified as potentially at risk for an HIV/HCV outbreak. 
To select these states, we ranked all 50 states using a 
composite of three indicators related to IDU, HIV, and 
HCV. The first indicator was new HIV cases attributable 
to IDU (rate per 100,000 population)35 because baseline 
IDU-related HIV rates provide a marker of future risk 
potential. Rates of new HIV cases attributable to IDU 
were collected from AIDSVu and are based on 2015 
data.35 The second indicator was acute HCV rate in 2016 
(per 100,000 population)36 based on a previous study13 
that used the measure as a proxy for IDU. Acute HCV 
rates were obtained from the CDC Surveillance for Viral 
Hepatitis website.36-39 The third indicator, opioid overdose 
death rate, was selected to show opioid-related burden in 
a state. Opioid overdose death rates were obtained from 
the National Institute on Drug Abuse (NIDA) from 2018, 
reflecting 2016 rates (per 100,000 population).40 
Based on these three indicators, we calculated a mean 
rank for each state with tied ranks averaged and selected 
the top 20 states by mean rank for use in our analyses 
(Figure 1). The selected states were primarily clustered 
among Northeast and Appalachian states, with three 
states located in the Southwest. Of these 20 states, nine 
had 20 percent or more of the population living in non-
metropolitan areas, according to the U.S. Department of 
Agriculture’s Economic Research Service.41 
2
Figure 1. Study Sample of 20 States at Potential Risk 
for HIV/HCV Outbreak
Sources: National Institute for Drug Abuse, 2016; AIDSVu, 2015; CDC 
Surveillance for Viral Hepatitis, 2016.
NOTE: States selected based on mean rank of a combination of opioid 
use, HIV and HCV indicators.
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Data and Measures
To understand the state-level resources in at-risk states 
we analyzed the 2016 Association of State and Territorial 
Health Officials (ASTHO) Profile Survey for state 
public health agency activities and the CDC’s state 2016 
Syringe Exchange Legislation data, comparing states 
with high rural population (20 percent or more of the 
total population) to those with a greater proportion 
of urban residents. At the county level, we used the 
2016 National Association of City and County Health 
Officials (NACCHO) National Profile of Local Health 
Departments to examine rural-urban differences in LHD 
activities related to HIV, substance use, and emergency 
preparedness. Of the 996 counties of interest included 
in the NACCHO data,  460 (46.2%) were urban counties 
and 536 (53.8%) were rural counties, including 334 rural 
adjacent counties (33.5% of total counties) and 202 rural, 
not adjacent counties (20.3% of total counties). The 
2016-17 Area Health Resources File (AHRF) provided 
data for county-level estimates of population and place 
characteristics, health professionals, and health facilities. 
Finally, we used the Rural-Urban Continuum Codes 
(RUCCs) to classify counties as urban if they were part of 
a metropolitan statistical area, rural adjacent if they were 
a non-metropolitan county that abutted an urban county, 
and rural not adjacent for non-metropolitan counties that 
did not border an urban county. In some instances, we 
combined rural adjacent and rural not adjacent counties 
to create a rural total category.
Analysis
We used R 3.5.1 (R Foundation for Statistical Computing, 
Vienna, Austria) to calculate mean rank scores for every 
state on opioid use, HIV, and HCV indicators to select the 
20 states for inclusion in this study. All other statistical 
analyses were conducted in SAS 9.4 (SAS Institute, Cary, 
NC). We used bivariate techniques to examine capacity 
differences across states and counties for the 20 study 
states, using chi-square tests or t-tests as appropriate. 
FINDINGS
State Provision of Services and Collaboration 
Among the 20 states identified as potentially at-risk for an 
HIV/HCV outbreak, nearly all state public health agencies 
provided screening for HIV and sexually transmitted 
infections (STIs) (96 percent of rural states compared 
with 100 percent of urban states), STD treatment (92 
percent of rural states compared with 100 percent of 
urban states), and infectious disease surveillance (100 
percent of both rural and urban states); undertook 
primary prevention activities for HIV (100 percent of 
rural states compared with 96 percent of urban states); 
and facilitated collaboration and information sharing 
between various agencies and organizations (85 percent 
and 96 percent of rural states reported collaborating with 
local public health agencies and hospitals, respectively, 
compared with 91 and 100 percent of urban states). There 
were no statistically significant differences observed 
between states with higher (20 percent or more) versus 
lower proportions of rural residents on these measures. 
However, public health agencies located in more rural 
at-risk states were significantly less likely than their 
counterparts with a smaller proportion of rural residents 
to maintain an HCV registry (50 percent of rural states 
compared with 78 percent of urban states, p = .04), to 
have a law authorizing syringe exchanges to exist within 
their borders (24 percent compared with 52 percent, p = 
.05), and to collaborate with law enforcement (85 percent 
compared with 100 percent, p = .05).
Figure 2. LHD Services and Staff among Rural and Urban Counties Within 20 States 
at Potential Risk for an HIV/HCV Outbreak
All residence differences significant at p<.05.
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County-Level Services and Staff
Among the 20 states in our study, we identified 
each county that had at least one LHD providing or 
contracting out public health services and analyzed its 
data regarding provision of services and staffing. LHDs 
in rural counties were less likely than LHDs in urban 
counties to provide (directly or through contract with 
another organization) services related to HIV/AIDS and 
other STIs, infectious disease surveillance activities, and 
mental health and substance use prevention activities 
(Figure 2). For example, while 85 percent of urban 
counties had an LHD that provided or contracted 
out screening services for HIV/AIDS, only 78 percent 
of rural counties had an LHD that offered screening 
directly or through a contract with another organization. 
Additionally, while 81 percent of urban counties had 
an LHD with a designated emergency preparedness 
coordinator, only 74 percent of rural counties had an 
LHD with this type of professional. Within our sample 
of states, rural not adjacent counties with an LHD were 
more likely than their urban counterparts to anticipate a 
reduction in the subsequent year’s budget (32 percent vs. 
22 percent, data not shown).
County-Level Partnerships and Collaboration
LHDs were asked to describe collaborations with external 
organizations during the past year through shared 
personnel or resources, written agreements, regularly 
scheduled meetings, or exchange of information. We 
observed rural-urban differences in these types of 
collaboration, especially among LHDs located in rural 
not-adjacent counties (Figure 3). About one-third of 
urban counties reported that they had some type of 
Figure 3. LHD Partnerships and Collaboration in Rural, Not Adjacent, Rural Adjacent 
and Urban Counties
All adjacency differences were significant at p<.05.  Data: NACCHO 2016 Profile Survey
LIMITATIONS
While state overdose death rates indicate significant 
opioid-related impact, we recognize that this measure 
does not consider opioid overdoses that did not result 
in death because of access to naloxone. The NACCHO 
Profile Survey had a response rate of 76 percent, meaning 
that some LHDs in our at-risk states were not captured 
by the survey. For example, only 63 percent of LHDs 
participated in West Virginia.17 In cases when there 
were multiple LHDs in the same county, we considered 
a service available in that county if any LHD provided 
that service—we did not capture whether multiple 
LHDs provided a service. Likewise, if a county did not 
have an LHD, we did not capture the absence of LHD-
provided services. Additionally, these analyses did not 
collaboration in the past year with community health 
centers, the criminal justice system, or local faith 
communities. In comparison, 11 percent of rural, not 
adjacent counties had partnered with a community health 
center and 8 percent had partnered with criminal justice 
or faith communities. This rate was slightly higher among 
rural adjacent counties, where about 17 percent had 
collaborated with these community organizations.
Population and Place Characteristics
Within at-risk states, rural counties had higher rates of 
individuals identifying as white or American Indian/
Alaska Native and older median age. Rural, not adjacent 
counties fared worse on indicators of educational 
attainment, employment, poverty, and household income 
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capture services provided by entities that were not LHDs 
or contracting with LHDs. For example, in addition to 
services provided or supported by LHDs, healthcare and 
community-based organizations may independently 
offer services such as screening and treatment for HIV/
AIDS, and SUD treatment services. The state and LHD 
activities examined in this brief may not represent all of 
the HIV, HCV, and OUD-related activities in a county. 
Additionally, findings may not reflect current activities, 
as data are primarily from 2016.
DISCUSSION AND POLICY IMPLICATIONS
Based on indicators of elevated HIV/HCV prevalence and 
opioid misuse, we classified 20 states as being at elevated 
risk of an HIV/HCV outbreak. Nearly half of these states 
had higher than average rural population, most of which 
were clustered in the Northeast and Appalachia. State-
level analyses could not identify whether resources 
differed between rural and urban areas of an individual 
state; however, we found that states where at least 20 
percent of residents are rural were less likely to have 
HCV registries or laws authorizing syringe exchange.
Our county-level analyses suggest that rural counties in 
the 20 higher-risk states may be vulnerable to an HIV/
HCV outbreak given that a smaller proportion of rural 
counties had an LHD that provided services related 
to HIV/HCV, substance use prevention and treatment, 
and emergency preparedness. Future research on 
the availability of HIV/HCV-related services in rural 
areas may benefit from including the presence of non-
LHD entities in analyses—including AIDS service 
organizations, clinics, hospitals, and social service 
Figure 4. Demographic Characteristics among At-Risk Counties
Residence differences significant at p<.001. Data: Area Health Resource File 2017-18 
linked to data from the US Department of Agriculture’s Economic Research Service, 
National Institute for Drug Abuse, AIDSVu, and CDC Surveillance for Viral Hepatitis.
organizations—to gain a more complete understanding 
of rural service availability. Another key finding of our 
county-level analyses is that a smaller proportion of rural 
counties had an LHD that reported collaborating with 
community health centers, the criminal justice system, 
or faith communities. Further research is needed to 
explore challenges related to establishing these types of 
collaborations in the rural context.
While rural communities are generally estimated to have 
lower rates of HIV than their urban counterparts, we 
know that an outbreak of HIV can spread rapidly through 
a small rural community.⁷ Our findings are evidence of 
rural-urban capacity differences in all four focus areas 
of the Ending the HIV Epidemic initiative: diagnoses, 
treatment, prevention, and response. They also suggest 
areas of opportunity for rural public health capacity 
building, such as fostering collaboration between LHDs 
and organizations such as community health centers, 
faith communities, and the criminal justice system. These 
types of partnerships could support and facilitate HIV/
HCV-related activities including community education 
programs, HIV/HCV testing opportunities, and linkage 
to medical care. Federal and state investment in funding 
to promote these partnership developments could be an 
important first step in helping rural communities to better 
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